Alicia C. Olivo - 13 Jan 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
EVP, GC & Business Development
Signature
/s/ Alicia C. Olivo
Issuer symbol
NEO
Transactions as of
13 Jan 2026
Net transactions value
$0
Form type
4
Filing time
15 Jan 2026, 16:22:08 UTC
Previous filing
28 Nov 2025
Next filing
24 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Olivo Alicia C EVP, GC & Business Development 9490 NEOGENOMICS WAY, FORT MYERS /s/ Alicia C. Olivo 15 Jan 2026 0001951869

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +59,382 +191% $0.000000 90,465 13 Jan 2026 Direct F1
transaction NEO Common Stock Tax liability $0 -15,145 -17% $0.000000 75,320 13 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 1,046 13 Jan 2026 Common Stock 1,046 $19.12 Direct F3
holding NEO Stock Option (Right to Buy) 1,024 13 Jan 2026 Common Stock 1,024 $27.34 Direct F4
holding NEO Stock Option (Right to Buy) 516 13 Jan 2026 Common Stock 516 $48.99 Direct F5
holding NEO Stock Option (Right to Buy) 1,117 13 Jan 2026 Common Stock 1,117 $46.10 Direct F6
holding NEO Stock Option (Right to Buy) 22,222 13 Jan 2026 Common Stock 22,222 $9.45 Direct F7
holding NEO Stock Option (Right to Buy) 46,355 13 Jan 2026 Common Stock 46,355 $10.05 Direct F8
holding NEO Stock Option (Right to Buy) 36,508 13 Jan 2026 Common Stock 36,508 $19.65 Direct F9
holding NEO Restricted Stock Unit 6,503 13 Jan 2026 Common Stock 6,503 $0.000000 Direct F10, F11
holding NEO Performance Stock Unit 19,508 13 Jan 2026 Common Stock 19,508 $0.000000 Direct F11, F12
holding NEO Stock Option (Right to Buy) 42,344 13 Jan 2026 Common Stock 42,344 $16.45 Direct F13
holding NEO Restricted Stock Unit 59,382 13 Jan 2026 Common Stock 59,382 $0.000000 Direct F11
holding NEO Performance Stock Unit 25,330 13 Jan 2026 Common Stock 25,330 $0.000000 Direct F11, F14
holding NEO Restricted Stock Unit 16,886 13 Jan 2026 Common Stock 16,886 $0.000000 Direct F11, F15
holding NEO Stock Option (Right to Buy) 107,450 13 Jan 2026 Common Stock 107,450 $13.05 Direct F16, F17
holding NEO Restricted Stock Unit 63,238 13 Jan 2026 Common Stock 63,238 $0.000000 Direct F11, F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2 Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F3 On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4 On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5 On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6 On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7 On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8 On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F9 On May 11, 2023, Ms. Olivo was granted 36,508 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F10 On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F11 Once vested, the shares of common stock are not subject to expiration.
F12 On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
F13 On February 23, 2024, Ms. Olivo was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F14 On February 23, 2024, Ms. Olivo was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F15 On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F16 This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F17 On February 21, 2025, Ms. Olivo was granted 107,450 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F18 On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.